StockMacro
Menu

iRadimed

$81.02 -13% in 6 monthsMarket cap $1.0B

IRMD on XNAS, Health Care, iRadimed Corporation, job postings

Measures activity, not value. Not investment advice.

Revenue rose 14% to $24.2M last quarter while the stock is down 7.4% over 12 months.

  • GoodNet income $24M over 12 months, up 13% on the year before

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
166
Website
iradimed.com
Listed
Nasdaq, US
Last results
30 Oct 2026
Next results
expected around 9 Feb 2027 (an estimate: a year ago it reported on 10 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $24.2M, net income $6.5M.
Quarter to 31 Dec 2021: revenue $11.9M, net income $3.9MQuarter to 31 Dec 2021: revenue $11.9M, net income $3.9MQuarter to 31 Mar 2022: revenue $12.3M, net income $2.5MQuarter to 31 Mar 2022: revenue $12.3M, net income $2.5MQuarter to 30 Jun 2022: revenue $12.7M, net income $3.2MQuarter to 30 Jun 2022: revenue $12.7M, net income $3.2MQuarter to 30 Sep 2022: revenue $13.4M, net income $3.4MQuarter to 30 Sep 2022: revenue $13.4M, net income $3.4MQuarter to 31 Dec 2022: revenue $14.9M, net income $3.7MQuarter to 31 Dec 2022: revenue $14.9M, net income $3.7MQuarter to 31 Mar 2023: revenue $15.5M, net income $3.4MQuarter to 31 Mar 2023: revenue $15.5M, net income $3.4MQuarter to 30 Jun 2023: revenue $16.1M, net income $4.2MQuarter to 30 Jun 2023: revenue $16.1M, net income $4.2MQuarter to 30 Sep 2023: revenue $16.5M, net income $5.1MQuarter to 30 Sep 2023: revenue $16.5M, net income $5.1MQuarter to 31 Dec 2023: revenue $17.5M, net income $4.5MQuarter to 31 Dec 2023: revenue $17.5M, net income $4.5MQuarter to 31 Mar 2024: revenue $17.6M, net income $4.1MQuarter to 31 Mar 2024: revenue $17.6M, net income $4.1MQuarter to 30 Jun 2024: revenue $17.9M, net income $4.9MQuarter to 30 Jun 2024: revenue $17.9M, net income $4.9MQuarter to 30 Sep 2024: revenue $18.3M, net income $5.0MQuarter to 30 Sep 2024: revenue $18.3M, net income $5.0MQuarter to 31 Dec 2024: revenue $19.4M, net income $5.1MQuarter to 31 Dec 2024: revenue $19.4M, net income $5.1MQuarter to 31 Mar 2025: revenue $19.5M, net income $4.7MQuarter to 31 Mar 2025: revenue $19.5M, net income $4.7MQuarter to 30 Jun 2025: revenue $20.4M, net income $5.8MQuarter to 30 Jun 2025: revenue $20.4M, net income $5.8MQuarter to 30 Sep 2025: revenue $21.2M, net income $5.6MQuarter to 30 Sep 2025: revenue $21.2M, net income $5.6MQuarter to 31 Dec 2025: revenue $22.7M, net income $6.4MQuarter to 31 Dec 2025: revenue $22.7M, net income $6.4MQuarter to 31 Mar 2026: revenue $22.0M, net income $5.8MQuarter to 31 Mar 2026: revenue $22.0M, net income $5.8MQuarter to 30 Jun 2026: revenue $20.5M, net income $5.2MQuarter to 30 Jun 2026: revenue $20.5M, net income $5.2MQuarter to 30 Sep 2026: revenue $24.2M, net income $6.5MQuarter to 30 Sep 2026: revenue $24.2M, net income $6.5M
31 Dec 2021RevenueNet incometallest bar $24.2M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$24.2M$6.5M
30 Jun 2026$20.5M$5.2M
31 Mar 2026$22.0M$5.8M
31 Dec 2025$22.7M$6.4M
30 Sep 2025$21.2M$5.6M
30 Jun 2025$20.4M$5.8M
31 Mar 2025$19.5M$4.7M
31 Dec 2024$19.4M$5.1M
30 Sep 2024$18.3M$5.0M
30 Jun 2024$17.9M$4.9M
31 Mar 2024$17.6M$4.1M
31 Dec 2023$17.5M$4.5M
30 Sep 2023$16.5M$5.1M
30 Jun 2023$16.1M$4.2M
31 Mar 2023$15.5M$3.4M
31 Dec 2022$14.9M$3.7M
30 Sep 2022$13.4M$3.4M
30 Jun 2022$12.7M$3.2M
31 Mar 2022$12.3M$2.5M
31 Dec 2021$11.9M$3.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $89.3M $80.5M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +11% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $24.0M $21.2M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $1.87 $1.65
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 75.5% 77.1% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 32.3% 30.9% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 26.8% 26.3% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 23.4% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $26.1M $14.8M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $63.3M $56.5M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$63.3M (net cash) -$56.5M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $8.32
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 43.2 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 11.6 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 10.9 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 9.7 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
iRadimedIRMD (this company) $1.0B43.211.6+11%26.8%
Integra LifeSciencesIART $1.0B79.20.62+0.8%0.8%
AlphatecATEC $1.0Bloss1.2+15%-10.3%
SpyGlass PharmaSGP $1.0Bloss–––
Si-BoneSIBN $1.1Bloss4.9+14%-6.2%
ArtivionAORT $886.0Mloss1.8+14%-3.7%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$123K

bought $0, sold $123K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+0.5%

212 13F filers vs 211

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

61%

7.9M shares held by 13F filers (30 Sep 2026) of 12.8M outstanding (30 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.6%

590K shares sold short (30 Oct 2026) of 12.8M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.1

590K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-12%

670K shares sold short in the report before, 590K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

63%

63% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 50%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+14%

$24.2M vs $21.2M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-89%

$130K vs $1.1M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$770K

the 12 months before: $776K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

1

1 article in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

1 article in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $81.02 on 20 Nov 2026, -7.4% over 12 months (12-month range $76.68 to $105.15)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $16.0M in the last 12 months (the 12 months before: -$5.6M).
Revenue per quarter. Revenue $24.2M in the latest quarter, +14% on a year earlier.
Capital spending per quarter. Capital spending $130K in the latest quarter, -89% on a year earlier.
Institutional holders (13F filers). 212 13F filers reported holding it in the latest 13F quarter, +20% on a year earlier.
Federal obligations. Federal obligations: $1.3M published in the last 12 months, +325% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
28 Apr 2026Sharp changeShort interest spike: short interest spike, 540K vs usual 230K (2026-04-15); 2.6x the same period a year earlier
17 Mar 2026Sharp changeShort interest spike: short interest spike, 519K vs usual 220K (2026-02-27); 2.6x the same period a year earlier
17 Feb 2026Sharp changeMany funds opening a new position: many funds opening a new position, 45 vs usual 20.50 (2025-12-31); 2.0x the same period a year earlier
2 Sep 20258-K and other filingsDirector or officer change
2 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Jun 20248-K and other filingsDelisting notice or listing transfer
6 Nov 20238-K and other filingsDirector or officer change
6 Nov 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 May 2023Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 6.4M vs usual 167K (2023-03-31); 34.9x the same period a year earlier
6 Oct 20228-K and other filingsDirector or officer change
6 Oct 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 May 20228-K and other filingsDirector or officer change
28 Apr 20228-K and other filingsDirector or officer change
28 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Feb 2022Sharp changeMany funds opening a new position: many funds opening a new position, 23 vs usual 7.50 (2021-12-31); 11.5x the same period a year earlier
Insider net buying (open market)
Month from 1 Nov 2021: -$3.4M published
Month from 1 Dec 2021: -$4.0M published
Month from 1 Jan 2022: -$1.7M published
Month from 1 Feb 2022: -$3.0M published
Month from 1 Mar 2022: -$2.9M published
Month from 1 Apr 2022: -$1.7M published
Month from 1 May 2022: -$335K published
Month from 1 Aug 2022: -$116K published
Month from 1 Dec 2022: -$29K published
Month from 1 Feb 2023: -$722K published
Month from 1 Mar 2023: -$1.9M published
Month from 1 Apr 2023: -$1.6M published
Month from 1 May 2023: -$2.0M published
Month from 1 Jun 2023: -$2.4M published
Month from 1 Jul 2023: -$1.8M published
Month from 1 Aug 2023: -$2.4M published
Month from 1 Sep 2023: -$1.8M published
Month from 1 Oct 2023: -$1.6M published
Month from 1 Nov 2023: -$1.8M published
Month from 1 Dec 2023: -$3.0M published
Month from 1 Jun 2024: -$84K published
Month from 1 Nov 2024: -$151K published
Month from 1 Dec 2024: -$135K published
Month from 1 Aug 2025: -$76K published
Month from 1 Sep 2025: -$713K published
Month from 1 Oct 2025: -$1.8M published
Month from 1 Nov 2025: -$2.9M published
Month from 1 Dec 2025: -$4.1M published
Month from 1 Jan 2026: -$2.0M published
Month from 1 Feb 2026: -$100K published
Month from 1 Mar 2026: -$3.0M published
Month from 1 Apr 2026: -$2.8M published
Month from 1 May 2026: -$3.3M published
Month from 1 Jun 2026: -$512K published
Month from 1 Sep 2026: -$123K published
Revenue per quarter
Quarter ended 31 Dec 2021: $11.9M, +39% on a year earlier; public on 5 Mar 2022
Quarter ended 31 Mar 2022: $12.3M, +33% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $12.7M, +30% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $13.4M, +23% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $14.9M, +25% on a year earlier; public on 3 Mar 2023
Quarter ended 31 Mar 2023: $15.5M, +26% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $16.1M, +27% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $16.5M, +23% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $17.5M, +17% on a year earlier; public on 2 Mar 2024
Quarter ended 31 Mar 2024: $17.6M, +14% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $17.9M, +11% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $18.3M, +11% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $19.4M, +11% on a year earlier; public on 7 Mar 2025
Quarter ended 31 Mar 2025: $19.5M, +11% on a year earlier; public on 6 May 2025
Quarter ended 30 Jun 2025: $20.4M, +14% on a year earlier; public on 2 Aug 2025
Quarter ended 30 Sep 2025: $21.2M, +16% on a year earlier; public on 4 Nov 2025
Quarter ended 31 Dec 2025: $22.7M, +17% on a year earlier; public on 7 Mar 2026
Quarter ended 31 Mar 2026: $22.0M, +13% on a year earlier; public on 2 May 2026
Quarter ended 30 Jun 2026: $20.5M, +0.3% on a year earlier; public on 1 Aug 2026
Quarter ended 30 Sep 2026: $24.2M, +14% on a year earlier; public on 31 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $91K, -2.9% on a year earlier; public on 5 Mar 2022
Quarter ended 31 Mar 2022: $183K, +39% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $189K, +74% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $193K, +28% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $258K, +184% on a year earlier; public on 3 Mar 2023
Quarter ended 31 Mar 2023: $6.4M, +3388% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $205K, +8.5% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $308K, +60% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $532K, +106% on a year earlier; public on 2 Mar 2024
Quarter ended 31 Mar 2024: $271K, -96% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $1.1M, +454% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $3.8M, +1137% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $2.8M, +425% on a year earlier; public on 7 Mar 2025
Quarter ended 31 Mar 2025: $3.7M, +1267% on a year earlier; public on 6 May 2025
Quarter ended 30 Jun 2025: $2.6M, +132% on a year earlier; public on 2 Aug 2025
Quarter ended 30 Sep 2025: $1.1M, -70% on a year earlier; public on 4 Nov 2025
Quarter ended 31 Dec 2025: $294K, -89% on a year earlier; public on 7 Mar 2026
Quarter ended 31 Mar 2026: $403K, -89% on a year earlier; public on 2 May 2026
Quarter ended 30 Jun 2026: $185K, -93% on a year earlier; public on 1 Aug 2026
Quarter ended 30 Sep 2026: $130K, -89% on a year earlier; public on 31 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 89; public on 14 Feb 2022
31 Mar 2022 report: 96; public on 16 May 2022
30 Jun 2022 report: 84; public on 15 Aug 2022
30 Sep 2022 report: 79; public on 14 Nov 2022
31 Dec 2022 report: 70; public on 14 Feb 2023
31 Mar 2023 report: 85; public on 15 May 2023
30 Jun 2023 report: 101; public on 14 Aug 2023
30 Sep 2023 report: 107; public on 14 Nov 2023
31 Dec 2023 report: 114; public on 14 Feb 2024
31 Mar 2024 report: 121; public on 15 May 2024
30 Jun 2024 report: 131; public on 14 Aug 2024
30 Sep 2024 report: 139; public on 14 Nov 2024
31 Dec 2024 report: 160; public on 14 Feb 2025
31 Mar 2025 report: 160; public on 15 May 2025
30 Jun 2025 report: 152; public on 14 Aug 2025
30 Sep 2025 report: 177; public on 14 Nov 2025
31 Dec 2025 report: 208; public on 17 Feb 2026
31 Mar 2026 report: 220; public on 15 May 2026
30 Jun 2026 report: 211; public on 14 Aug 2026
30 Sep 2026 report: 212; public on 16 Nov 2026
Federal obligations
Month from 1 Jan 2022: $101K published
Month from 1 Apr 2022: $43K published
Month from 1 May 2022: $29K published
Month from 1 Jun 2022: $16K published
Month from 1 Jul 2022: $0 published
Month from 1 Aug 2022: $170K published
Month from 1 Sep 2022: $75K published
Month from 1 Oct 2022: $5K published
Month from 1 Nov 2022: -$26.5 published
Month from 1 Dec 2022: $152K published
Month from 1 Mar 2023: $531K published
Month from 1 Apr 2023: $13K published
Month from 1 May 2023: $0 published
Month from 1 Jun 2023: $49K published
Month from 1 Aug 2023: $104K published
Month from 1 Oct 2023: $5K published
Month from 1 Mar 2024: $127K published
Month from 1 Apr 2024: $60K published
Month from 1 May 2024: $38K published
Month from 1 Jul 2024: $39K published
Month from 1 Aug 2024: $188K published
Month from 1 Sep 2024: $122K published
Month from 1 Oct 2024: $107K published
Month from 1 Nov 2024: $318K published
Month from 1 Dec 2024: $998 published
Month from 1 Apr 2025: $192K published
Month from 1 Aug 2025: $123K published
Month from 1 Feb 2026: $56K published
Month from 1 Mar 2026: $110K published
Month from 1 Apr 2026: $102K published
Month from 1 May 2026: $16K published
Month from 1 Jun 2026: $0 published
Month from 1 Jul 2026: $163K published
Month from 1 Aug 2026: $278K published
Month from 1 Sep 2026: $281K published
Month from 1 Oct 2026: $232K published
Month from 1 Nov 2026: $105K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $123K (8 Sep 2026), 82% below its normal reading of $674K; higher than 20% of its own history.
  • Insider net buying (open market): Insiders sold a net $16.0M in the last 12 months (the 12 months before: -$5.6M).
  • Revenue per quarter: Revenue $24.2M in the latest quarter, +14% on a year earlier.
  • Capital spending per quarter: Capital spending $130K in the latest quarter, -89% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 1 sale, $123K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
8 Sep 2026Monty K AllenDirectorSell1,419$86.41$123KForm 4
4 Jun 2026Hilda Frederique Scharen-GuivelDirectorSell3,000$95.00$285KForm 4
2 Jun 2026Roger E. SusiCEO, President, ChairmanSellplanned in advance (10b5-1)2,500$90.60$227KForm 4
28 May 2026Roger E. SusiCEO, President, ChairmanSellplanned in advance (10b5-1)7,500$92.14$691KForm 4
20 May 2026Roger E. SusiCEO, President, ChairmanSellplanned in advance (10b5-1)7,500$87.64$657KForm 4
13 May 2026Roger E. SusiCEO, President, ChairmanSellplanned in advance (10b5-1)7,500$84.18$631KForm 4
6 May 2026Roger E. SusiCEO, President, ChairmanSellplanned in advance (10b5-1)7,500$85.71$643KForm 4
30 Apr 2026Roger E. SusiCEO, President, ChairmanSellplanned in advance (10b5-1)7,500$87.69$658KForm 4

212 institutions reported shares at the end of Q3 2026, 61% of the shares outstanding; 27 opened a position, 22 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.959K7.50%$82.7M-9,154-0.9%
Copeland Capital Management, LLC382K2.99%$32.9M-9,847-2.5%
Vanguard Capital Management LLC368K2.88%$31.8M+3,458+0.9%
Kayne Anderson Rudnick Investment Management LLC354K2.77%$30.5M-43K-11%
Renaissance Technologies LLC351K2.74%$30.2M-44K-11%
Geode Capital Management, LLC296K2.32%$25.5M+6,118+2.1%
T. Rowe Price Investment Management, Inc.260K2.03%-59K-18%
Two Sigma Investments, LP247K1.93%$21.3M+64K+35%
State Street Corp238K1.86%$20.5M+16K+7.3%
Dimensional Fund Advisors LP231K1.81%$19.9M+1,638+0.7%

Company events

All 25 company events

Nothing in 12 months; the latest was filed 2 Sep 2025. Results releases and routine reports are left out.

FiledWhat happenedSource
2 Sep 2025Director or officer change8-K
7 Jun 2024Delisting notice or listing transfer8-K
3 Jun 2024Signed a major agreement8-K
6 Nov 2023Director or officer change8-K
3 Feb 2023Signed a major agreement8-K
4 Nov 2022Signed a major agreementSame filing: took on new debt8-K
6 Oct 2022Director or officer change8-K
26 May 2022Director or officer change8-K

The 5 newest of 22 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

17 Mar 2026confirmed

Confirmed across sources Institutional holdings and Short interest and volume

iRadimed (IRMD): saw 45 13F filers open a new position in the quarter ended 31 Dec 2025, 2.0× the same quarter last year, while it had 519K shares sold short in the 27 Feb 2026 report, 2.6× the same report last year. Two unrelated kinds of activity within 28 days.

  • Institutional holdings: Many funds opening a new position, became public on 17 Feb 2026
  • Short interest and volume: Short interest spike, became public on 11 Mar 2026
2023-12-31: 112024-03-31: 232024-06-30: 222024-09-30: 192024-12-31: 232025-03-31: 152025-06-30: 122025-09-30: 312025-12-31: 45
The quarter ended 31 Dec 2025 against the 8 quarters before it. this quarterearliernormal: 20.5
See the evidence (2 changes)

Institutional holdings: Many funds opening a new position became public on 17 Feb 2026

iRadimed saw 45 13F filers open a new position in the quarter ended 31 Dec 2025, 2.0× the same quarter last year.

This period
45 (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
20.5
Typical spread (median absolute deviation)
4
How far from its usual level
+4.1
Same quarter last year
23
History used
4,110 days
2023-12-31: 112024-03-31: 232024-06-30: 222024-09-30: 192024-12-31: 232025-03-31: 152025-06-30: 122025-09-30: 312025-12-31: 45
the quarter ended 31 Dec 20258 earlier quartersnormal: 20.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 11 Mar 2026

iRadimed had 519K shares sold short in the 27 Feb 2026 report, 2.6× the same report last year.

This period
519K (the 27 Feb 2026 report)
Normal report (median of 24 earlier)
220K
Typical spread (median absolute deviation)
29K
How far from its usual level
+6.0
Same report last year
201K
History used
2,982 days
2025-02-28: 201K2025-03-14: 237K2025-03-31: 188K2025-04-15: 207K2025-04-30: 198K2025-05-15: 197K2025-05-30: 230K2025-06-13: 238K2025-06-30: 231K2025-07-15: 227K2025-07-31: 212K2025-08-15: 193K2025-08-29: 152K2025-09-15: 154K2025-09-30: 142K2025-10-15: 160K2025-10-31: 200K2025-11-14: 270K2025-11-28: 268K2025-12-15: 310K2025-12-31: 388K2026-01-15: 454K2026-01-30: 478K2026-02-13: 476K2026-02-27: 519K
the 27 Feb 2026 report24 earlier reportsnormal: 220K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 25 Apr 2026Short interest and volume change

    had 540K shares sold short in the 15 Apr 2026 report, 2.6× the same report last year.

    Same report last year: 207K; its normal report is 230K.

    See the evidence
    This period
    540K (the 15 Apr 2026 report)
    Normal report (median of 24 earlier)
    230K
    Typical spread (median absolute deviation)
    55K
    How far from its usual level
    +3.8
    Same report last year
    207K
    History used
    3,029 days
    2025-04-15: 207K2025-04-30: 198K2025-05-15: 197K2025-05-30: 230K2025-06-13: 238K2025-06-30: 231K2025-07-15: 227K2025-07-31: 212K2025-08-15: 193K2025-08-29: 152K2025-09-15: 154K2025-09-30: 142K2025-10-15: 160K2025-10-31: 200K2025-11-14: 270K2025-11-28: 268K2025-12-15: 310K2025-12-31: 388K2026-01-15: 454K2026-01-30: 478K2026-02-13: 476K2026-02-27: 519K2026-03-13: 492K2026-03-31: 499K2026-04-15: 540K
    the 15 Apr 2026 report24 earlier reportsnormal: 230K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 17 Mar 2026several at once

    saw 45 13F filers open a new position in the quarter ended 31 Dec 2025, 2.0× the same quarter last year, while it had 519K shares sold short in the 27 Feb 2026 report, 2.6× the same report last year. Two unrelated kinds of activity within 28 days.

    See the evidence (2 changes)

    Institutional holdings: Many funds opening a new position became public on 17 Feb 2026

    iRadimed saw 45 13F filers open a new position in the quarter ended 31 Dec 2025, 2.0× the same quarter last year.

    This period
    45 (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    20.5
    Typical spread (median absolute deviation)
    4
    How far from its usual level
    +4.1
    Same quarter last year
    23
    History used
    4,110 days
    2023-12-31: 112024-03-31: 232024-06-30: 222024-09-30: 192024-12-31: 232025-03-31: 152025-06-30: 122025-09-30: 312025-12-31: 45
    the quarter ended 31 Dec 20258 earlier quartersnormal: 20.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 11 Mar 2026

    iRadimed had 519K shares sold short in the 27 Feb 2026 report, 2.6× the same report last year.

    This period
    519K (the 27 Feb 2026 report)
    Normal report (median of 24 earlier)
    220K
    Typical spread (median absolute deviation)
    29K
    How far from its usual level
    +6.0
    Same report last year
    201K
    History used
    2,982 days
    2025-02-28: 201K2025-03-14: 237K2025-03-31: 188K2025-04-15: 207K2025-04-30: 198K2025-05-15: 197K2025-05-30: 230K2025-06-13: 238K2025-06-30: 231K2025-07-15: 227K2025-07-31: 212K2025-08-15: 193K2025-08-29: 152K2025-09-15: 154K2025-09-30: 142K2025-10-15: 160K2025-10-31: 200K2025-11-14: 270K2025-11-28: 268K2025-12-15: 310K2025-12-31: 388K2026-01-15: 454K2026-01-30: 478K2026-02-13: 476K2026-02-27: 519K
    the 27 Feb 2026 report24 earlier reportsnormal: 220K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  3. 11 Mar 2026Short interest and volume change

    had 519K shares sold short in the 27 Feb 2026 report, 2.6× the same report last year.

    Same report last year: 201K; its normal report is 220K.

    See the evidence
    This period
    519K (the 27 Feb 2026 report)
    Normal report (median of 24 earlier)
    220K
    Typical spread (median absolute deviation)
    29K
    How far from its usual level
    +6.0
    Same report last year
    201K
    History used
    2,982 days
    2025-02-28: 201K2025-03-14: 237K2025-03-31: 188K2025-04-15: 207K2025-04-30: 198K2025-05-15: 197K2025-05-30: 230K2025-06-13: 238K2025-06-30: 231K2025-07-15: 227K2025-07-31: 212K2025-08-15: 193K2025-08-29: 152K2025-09-15: 154K2025-09-30: 142K2025-10-15: 160K2025-10-31: 200K2025-11-14: 270K2025-11-28: 268K2025-12-15: 310K2025-12-31: 388K2026-01-15: 454K2026-01-30: 478K2026-02-13: 476K2026-02-27: 519K
    the 27 Feb 2026 report24 earlier reportsnormal: 220K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 17 Feb 2026Institutional holdings change

    saw 45 13F filers open a new position in the quarter ended 31 Dec 2025, 2.0× the same quarter last year.

    Same quarter last year: 23; its normal quarter is 20.5.

    See the evidence
    This period
    45 (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    20.5
    Typical spread (median absolute deviation)
    4
    How far from its usual level
    +4.1
    Same quarter last year
    23
    History used
    4,110 days
    2023-12-31: 112024-03-31: 232024-06-30: 222024-09-30: 192024-12-31: 232025-03-31: 152025-06-30: 122025-09-30: 312025-12-31: 45
    the quarter ended 31 Dec 20258 earlier quartersnormal: 20.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  5. 2 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 2 Sep 2025Filings record

    Director or officer change

  7. 7 Jun 2024Filings record

    Delisting notice or listing transfer

  8. 6 Nov 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 6 Nov 2023Filings record

    Director or officer change

  10. 9 May 2023Financials change

    spent $6.4M on capital projects in the quarter ended 31 Mar 2023, 35× the same quarter last year.

    Same quarter last year: $183K; its normal quarter is $167K.

    See the evidence
    This period
    $6.4M (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    $167K
    Typical spread (median absolute deviation)
    $30K
    How far from its usual level
    +6.2
    Same quarter last year
    $183K
    History used
    3,469 days
    2021-03-31: $132K2021-06-30: $108K2021-09-30: $151K2021-12-31: $91K2022-03-31: $183K2022-06-30: $189K2022-09-30: $193K2022-12-31: $258K2023-03-31: $6.4M
    the quarter ended 31 Mar 20238 earlier quartersnormal: $167K

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  11. 6 Oct 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 6 Oct 2022Filings record

    Director or officer change

  13. 26 May 2022Filings record

    Director or officer change

  14. 28 Apr 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 28 Apr 2022Filings record

    Director or officer change

  16. 14 Feb 2022Institutional holdings change

    saw 23 13F filers open a new position in the quarter ended 31 Dec 2021, 12× the same quarter last year.

    Same quarter last year: 2; its normal quarter is 7.5.

    See the evidence
    This period
    23 (the quarter ended 31 Dec 2021)
    Normal quarter (median of 8 earlier)
    7.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +4.2
    Same quarter last year
    2
    History used
    2,649 days
    2019-12-31: 52020-03-31: 92020-06-30: 92020-09-30: 52020-12-31: 22021-03-31: 62021-06-30: 102021-09-30: 152021-12-31: 23
    the quarter ended 31 Dec 20218 earlier quartersnormal: 7.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  17. 12 Jul 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 12 Jul 2021Filings record

    Director or officer change

  19. 11 Feb 2021Filings record

    A major agreement ended

  20. 16 Jul 2020Filings record

    Director or officer change

  21. 18 Jun 2020Filings record

    Director or officer change

  22. 29 May 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 29 May 2020Filings record

    Director or officer change

  24. 26 Feb 2020Filings record

    Director or officer change

  25. 7 Jan 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  26. 7 Jan 2020Filings record

    Director or officer change

  27. 26 Aug 2019Filings record

    Director or officer change

  28. 29 Jul 2019Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  29. 29 Jul 2019Filings record

    Director or officer change

  30. 14 Nov 2018Institutional holdings change

    saw 22 13F filers open a new position in the quarter ended 30 Sep 2018, 7.3× the same quarter last year.

    Same quarter last year: 3; its normal quarter is 6.5.

    See the evidence
    This period
    22 (the quarter ended 30 Sep 2018)
    Normal quarter (median of 8 earlier)
    6.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +4.2
    Same quarter last year
    3
    History used
    1,461 days
    2016-09-30: 132016-12-31: 72017-03-31: 42017-06-30: 62017-09-30: 32017-12-31: 72018-03-31: 42018-06-30: 152018-09-30: 22
    the quarter ended 30 Sep 20188 earlier quartersnormal: 6.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  31. 24 Sep 2018Filings record

    Director or officer change

  32. 21 Mar 2018Insiders record

    Susi Roger E. (CEO, President, Chairman) bought 1,000 shares of IRMD ($13,850) (dated 20 Mar 2018)

  33. 30 Mar 2017Filings record

    Director or officer change

  34. 11 Feb 2017Insiders record

    Susi Roger E. (CEO, President, Chairman) bought 10,000 shares of IRMD ($86,000) (dated 10 Feb 2017)

  35. 2 Dec 2016Insiders record

    Susi Roger E. (CEO, President, Chairman) bought 5,000 shares of IRMD ($56,200) (dated 1 Dec 2016)

  36. 17 Nov 2016Insiders record

    Susi Roger E. (CEO, President, Chairman) bought 5,000 shares of IRMD ($52,300) (dated 16 Nov 2016)

  37. 28 Jun 2016Filings record

    Director or officer change

  38. 29 Mar 2016Filings record

    Director or officer change

Not listed: 362 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001325618
Ticker
IRMD
Domain
iradimed.com
Hq location
FL|ORLANDO|32826 (1 unverified)
Name
iRadimed Corporation
Uei
XUFTRBBCDYH7
  • SEC Form 13F institutional holdings441 data points30 Sep 2014 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)140 records11 Jan 2016 to 30 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1021 data points31 Dec 2012 to 30 Oct 2026
  • SEC Form 4 insider transactions245 records, 896 data points22 Feb 2016 to 8 Sep 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards312 data points29 Dec 2008 to 17 Nov 2026